Pembrolizumab Non-Neutralizing Antibody [SAA2581] is a monoclonal anti-drug antibody (ADA) offered by Assay Genie for research investigating immunogenicity against Pembrolizumab. It is intended for the detection and characterisation of anti-Pembrolizumab antibody responses and has been supplied for use in ELISA.
Anti-drug antibodies are a central readout in biotherapeutic development, where immunogenicity against a molecule such as Pembrolizumab can alter clearance, exposure and clinical response. This clone is characterised as non-neutralizing, binding Pembrolizumab without blocking its target interaction, which makes it suited to total-ADA and bridging assay formats. Supplied in 50 µg, 100 µg. For research use only; not for diagnostic or therapeutic procedures.
Product Name:
Pembrolizumab Non-Neutralizing Antibody [SAA2581]
Size:
50 µg, 100 µg
Product SKU:
GXDA00244
Target:
Pembrolizumab
Antibody Type:
Monoclonal
Clone ID:
SAA2581
Buffer:
0.01M PBS pH 7.4
Storage & Shipping:
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Format:
Liquid
Applications:
ELISA
Antibody Isotype:
IgG
Purity:
>95% as determined by SDS-PAGE.
Purification:
Protein A/G purified from cell culture supernatant.
![Anti-Pembrolizumab Non-Neutralizing Antibody [SAA2581]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/1280x1280/products/279704/756832/assay-genie-antibody-flow__82852.1785155924.jpg?c=2?imbypass=on "Anti-Pembrolizumab Non-Neutralizing Antibody [SAA2581]")
![Anti-Pembrolizumab Non-Neutralizing Antibody [SAA2581]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/608x608/products/279704/756832/assay-genie-antibody-flow__82852.1785155924.jpg?c=2 "Anti-Pembrolizumab Non-Neutralizing Antibody [SAA2581]")
![Anti-Pembrolizumab Non-Neutralizing Antibody [SAA2582]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279705/756833/assay-genie-antibody-flow__92696.1785155924.jpg?c=2 "Anti-Pembrolizumab Non-Neutralizing Antibody [SAA2582]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2817]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279759/756955/AS870153-Bioactivity-binding-1__77334.1785163371.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2817]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2817]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279759/756956/AS870153-Bioactivity-binding-2__22534.1785163374.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2817]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2584]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279707/756932/AS870133-Bioactivity-binding-2__38429.1785163316.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2584]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2584]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279707/756933/AS870133-Bioactivity-binding-1__84556.1785163319.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2584]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2583]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279706/756930/AS870123-Bioactivity-binding-2__95735.1785163312.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2583]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2583]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279706/756931/AS870123-Bioactivity-binding-1__11055.1785163314.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2583]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2816]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279758/756953/AS870143-Bioactivity-binding-1__81141.1785163367.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2816]")
![Anti-Pembrolizumab Neutralizing Antibody [SAA2816]](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/279758/756954/AS870143-Bioactivity-binding-2__37441.1785163369.jpg?c=2 "Anti-Pembrolizumab Neutralizing Antibody [SAA2816]")